Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. es.investing.com › news › company-newsCantor Fitzgerald inicia la cobertura de ADC Therapeutics con ...

    Hace 1 día · El jueves, Cantor Fitzgerald comenzó a cubrir las acciones de ADC Therapeutics (NYSE:ADCT), asignando una calificación de Sobreponderar a la acción. La firma destacó el potencial de la empresa ...

  2. www.nasdaq.com › articles › cantor-fitzgeraldCantor Fitzgerald Initiates Coverage of ADC Therapeutics ...

    22 de may. de 2024 · Fintel reports that on May 30, 2024, Cantor Fitzgerald initiated coverage of ADC Therapeutics with a Overweight recommendation. Analyst Price Forecast Suggests 196.51% Upside

  3. www.bloomberg.com › news › articlesCantor Fitzgerald Accuses Data Firm of ‘Extortion’ in Lawsuit

    Hace 1 día · Cantor Fitzgerald sued the firm that hosts some of its “most critical and sensitive data,” claiming IT Convergence Inc. tried to “extort” money from it.. According to a lawsuit filed ...

  4. es.investing.com › news › company-newsCantor Fitzgerald mantiene el objetivo para las acciones de ...

    22 de may. de 2024 · El miércoles, Cantor Fitzgerald mantuvo su calificación de Sobreponderar y un objetivo de precio de 300,00 $ para las acciones de CyberArk Software (NASDAQ:CYBR), tras su participación en la...

  5. Videos

    Ver todo

  6. es.investing.com › news › company-newsCantor Fitzgerald fija un objetivo para las acciones de ...

    17 de may. de 2024 · El viernes, Cantor Fitzgerald inició la cobertura de AbbVie Inc . (NYSE: ABBV ), una empresa farmacéutica mundial, asignando una calificación de Sobreponderar y estableciendo un objetivo de...

  7. www.nasdaq.com › articles › cantor-fitzgeraldCantor Fitzgerald Upgrades EVgo (EVGO) | Nasdaq

    8 de may. de 2024 · May 09, 2024 — 11:04 pm EDT. Written by George Maybach for Fintel -> Fintel reports that on May 9, 2024, Cantor Fitzgerald upgraded their outlook for EVgo ( NasdaqGS:EVGO) from Neutral to...

  8. fintel.io › news › cantor-fitzgerald-initiatesCantor Fitzgerald Initiates Coverage of ADC Therapeutics ...

    Hace 23 horas · Fintel reports that on May 30, 2024, Cantor Fitzgerald initiated coverage of ADC Therapeutics ( NYSE:ADCT) with a Overweight recommendation. Analyst Price Forecast Suggests 196.51% Upside. As of May 22, 2024, the average one-year price target for ADC Therapeutics is 10.20. The forecasts range from a low of 8.08 to a high of $13.65.